Seroprevalence of SARS-CoV-2 IgG significantly varies with age: results from a mass population screening (SARS-2-SCREEN-CdA).

Authors

Gabriele Pagani, Federico Conti, Andrea Giacomelli, Dario Bernacchia, Rossana Rondanin, Andrea Prina, Vittore Scolari, Cecilia Eugenia Gandolfi, Silvana Castaldi, Giuseppe Marano, Cosimo Ottomano, Patrizia Boracchi, Elia Mario Biganzoli, Massimo Galli

Castiglione D’Adda is one of the towns earlier and more severely affected by the SARS-CoV-2 epidemic in Lombardy. In a mass screening involving 4174 out of about 4550 total inhabits, significant age-related differences in anti SARS-CoV-2 IgG seroprevalence were found, with the lowest prevalence in the youngest inhabitants.

https://medrxiv.org/cgi/content/short/2020.06.24.20138875.full.pdf

Overview of SARS-COV-2 studies seroprevalence in context of the worldwide  COVID-19 pandemie. You can register a study here: Contribute

serohub@helmholtz-hzi.de
@serohub on Twitter
hzi-braunschweig/serohub on GitHub